“NON-INVASIVE MONITORING OF EGFR MUTATIONS IN NONSMALL CELL LUNG CANCER (NSCLC) DURING TARGETED THERAPY: STATE OF THE ART AND OUR EXPERIENCE”. Voprosy Onkologii, vol. 62, no. 4, Dec. 2016, pp. 513-8, https://doi.org/10.37469/0507-3758-2016-62-4-513-518.